VABRITZA Trademark

Trademark Overview

On Wednesday, May 27, 2015, a trademark application was filed for VABRITZA with the United States Patent and Trademark Office. The USPTO has given the VABRITZA trademark a serial number of 86641997. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 23, 2024. This trademark is owned by Glaxo Group Limited. The VABRITZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
vabritza

General Information

Serial Number86641997
Word MarkVABRITZA
Filing DateWednesday, May 27, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 23, 2024
Registration Number5258565
Registration DateTuesday, August 8, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "VABRITZA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, February 23, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 8, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 8, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, July 5, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, June 15, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, June 30, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 15, 2017TEAS DELETE 1(B) BASIS RECEIVED
Thursday, December 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2016SOU EXTENSION 1 GRANTED
Tuesday, December 6, 2016SOU EXTENSION 1 FILED
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, June 28, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 29, 2016WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, March 15, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 14, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 14, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 7, 2016ASSIGNED TO LIE
Thursday, February 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 8, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 8, 2015NON-FINAL ACTION E-MAILED
Tuesday, September 8, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 8, 2015ASSIGNED TO EXAMINER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 30, 2015NEW APPLICATION ENTERED

Related Keywords

vabritza pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological